Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire VinFuture Prize empowered the woman scientist Dr. Firdausi Qadri to give back to Bangladesh
Society Việt Nam strengthens cooperation in measles prevention with int'l partners as vaccination drops
Media-OutReach Newswire Health2Sync Completes an Oversubscribed Round of US$20 Million to Fuel Market Expansion and Prepares for Public Listing